Opendata, web and dolomites

FibroFix SIGNED

FibroFix™Cartilage, an innovative implant for cartilage repair and regeneration, introducing a new paradigm in osteoarthritis (OA) treatment.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 FibroFix project word cloud

Explore the words cloud of the FibroFix project. It provides you a very rough idea of what is the project "FibroFix" about.

half    mobility    prevention    13m    characterised    innovative    prevalence    ing    frequent    trade    disease    grant    joint    additional    public    minimum    smooth    complications    supports    total    clinical    tkr    round    effectiveness    finance    biocompatible    25m    country    biostable    injuries    treatment    health    resilient    combination    bones    led    heart    involve    severe    disability    rubbing    deterioration    times    lengthy    shifting    solution    knee    hospitalizations    postponement    biomaterials    regeneration    quality    recourse    oa    durable    expensive    articular    rehabilitation    worldwide    replacement    almost    drawbacks    inefficient    potentially    productivity    fibrofix    stiffness    decreased    paradigm    unmet    pain    resurfacing    11    orthopaedics    life    osteoarthritic    ratio    economic    regenerative    repair    lesions    emulates    chronic    pressing    cartilage    orthopaedic    lubricious    seeking    prolonged    treatments    osteoarthritis    burdens    orthox    investment    solutions    function    ultimate   

Project "FibroFix" data sheet

The following table provides information about the project.

Coordinator
ORTHOX LIMITED 

Organization address
address: 66 INNOVATION DRIVE MILTON PARK
city: ABINGDON
postcode: OX14 4RQ
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.orthox.co.uk/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-01-01   to  2019-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ORTHOX LIMITED UK (ABINGDON) coordinator 50˙000.00

Map

 Project objective

Cartilage deterioration and injuries often lead to osteoarthritis (OA) – a long-term chronic disease resulting in bones rubbing together and creating pain, stiffness and severe disability. Knee cartilage injuries are very common and almost half of them go on to develop OA, which is second only to heart disease as a cause of work disability. Resulting from decreased quality of life, hospitalizations and loss of productivity, the economic cost of OA is particularly high in every country that it has been estimated. Currently, all treatments available, including Total Knee joint Replacement (TKR) as the ultimate recourse, are inefficient and expensive: they involve pain, lengthy rehabilitation, frequent complications and high costs. Therefore, given the increasing prevalence of knee OA, its associated burdens and the drawbacks of all available treatments, it is becoming increasingly important to develop an innovative cost-effective solution to this major public health problem worldwide.

FibroFix™ Cartilage is a well characterised, regenerative orthopaedic repair product to address the unmet and pressing clinical need of large and/or osteoarthritic articular cartilage lesions in the knee, developed by Orthox. It is biostable, biocompatible, emulates cartilage function and supports cartilage regeneration at the minimum cost effectiveness ratio. It allows resurfacing of large and/or potentially OA cartilage lesions, prolonged use of the joint, increased mobility, reduced pain and postponement or prevention of TKR. Smooth, robust, resilient, durable and lubricious, it is a unique combination to be applied in orthopaedics and biomaterials shifting the paradigm in knee OA treatment and up to 10 times less expensive than other solutions.

Over the previous 8 years, Orthox have led 11 major grant-funded programmes, raising more than €13M to finance product development. We are now seeking an additional €2.25M for the second investment round.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "FIBROFIX" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "FIBROFIX" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

MCBD (2019)

MCBD (MULTI-CORE BIOPSY DEVICE) INNOVATIVE BIOPSY TECHNOLOGY FOR THE NEW ERA OF TARGETED MEDICINE

Read More  

SmartDegrees (2020)

First anti-fraud plataform for the registration and certification of diplomas and academic certificates based in blockchain

Read More  

COPI (2020)

Carbon Offset Plug-in

Read More